Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

A Pragmatic Cluster Randomized Trial of an Electronic Clinical Decision Support System to Improve Chronic Kidney Disease Management in Primary Care: Design, Rationale, and Implementation Experience.

Khoong EC, Karliner L, Lo L, Stebbins M, Robinson A, Pathak S, Santoyo-Olsson J, Scherzer R, Peralta CA.

JMIR Res Protoc. 2019 Jun 7;8(6):e14022. doi: 10.2196/14022.

2.

Development and testing of a web module to IMPROVE generic prescribing of oral contraceptives among primary care physicians.

Lenti G, Norenberg A, Farnan JM, Weissman A, Cook M, Shah N, Moriates C, Wallingford S, Lynch S, Stebbins M, Millard S, Samarth A, Zhang JX, Thaver A, Meltzer DO, Oguntimein M, Frost M, Arora VM.

J Clin Pharm Ther. 2019 Aug;44(4):579-587. doi: 10.1111/jcpt.12853. Epub 2019 Jun 1.

PMID:
31152684
3.

Human pluripotent stem cell-derived brain pericyte-like cells induce blood-brain barrier properties.

Stebbins MJ, Gastfriend BD, Canfield SG, Lee MS, Richards D, Faubion MG, Li WJ, Daneman R, Palecek SP, Shusta EV.

Sci Adv. 2019 Mar 13;5(3):eaau7375. doi: 10.1126/sciadv.aau7375. eCollection 2019 Mar.

4.

Modeling specialty medicine access: Understanding key health system processes and players.

Cocohoba J, Pohlman B, Tran JS, Kirkham H, Joyce C, Clark K, Stebbins M.

J Am Pharm Assoc (2003). 2019 Jan - Feb;59(1):43-50.e3. doi: 10.1016/j.japh.2018.09.004. Epub 2018 Nov 8.

PMID:
30416069
5.

Modeling Group B Streptococcus and Blood-Brain Barrier Interaction by Using Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells.

Kim BJ, Bee OB, McDonagh MA, Stebbins MJ, Palecek SP, Doran KS, Shusta EV.

mSphere. 2017 Nov 1;2(6). pii: e00398-17. doi: 10.1128/mSphere.00398-17. eCollection 2017 Nov-Dec.

6.

Activation of RARα, RARγ, or RXRα Increases Barrier Tightness in Human Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells.

Stebbins MJ, Lippmann ES, Faubion MG, Daneman R, Palecek SP, Shusta EV.

Biotechnol J. 2018 Feb;13(2). doi: 10.1002/biot.201700093. Epub 2017 Sep 28.

7.

A preliminary study of patient-specific mechanical properties of diabetic and healthy plantar soft tissue from gated magnetic resonance imaging.

Williams ED, Stebbins MJ, Cavanagh PR, Haynor DR, Chu B, Fassbind MJ, Isvilanonda V, Ledoux WR.

Proc Inst Mech Eng H. 2017 Jul;231(7):625-633. doi: 10.1177/0954411917695849. Epub 2017 Mar 17.

PMID:
28661227
8.

Enhancing Transparency at the US Food and Drug Administration: Moving Beyond the 21st Century Cures Act.

Sharfstein JM, Stebbins M.

JAMA. 2017 Apr 25;317(16):1621-1622. doi: 10.1001/jama.2017.2481. No abstract available.

PMID:
28288264
9.

An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells.

Canfield SG, Stebbins MJ, Morales BS, Asai SW, Vatine GD, Svendsen CN, Palecek SP, Shusta EV.

J Neurochem. 2017 Mar;140(6):874-888. doi: 10.1111/jnc.13923. Epub 2017 Feb 14.

10.

Gender Differences in Perceived Unmet Treatment Needs Among Persons With and Without Co-occurring Disorders.

Manuel JI, Stebbins MB, Wu E.

J Behav Health Serv Res. 2018 Jan;45(1):1-12. doi: 10.1007/s11414-016-9530-y.

11.

Comprehensive Medication Management programs: 2015 status in Southern California.

Butler A, Dehner M, Gates RJ, Shane P, Chu M, DeMartini L, Stebbins M, Núñez de Ybarra J, Peck C, McInnis T, Chen S.

Res Social Adm Pharm. 2017 Jan - Feb;13(1):63-87. doi: 10.1016/j.sapharm.2016.02.003. Epub 2016 Mar 4. No abstract available.

PMID:
27234647
12.

SCIENTIFIC COMMUNITY. Preprints for the life sciences.

Berg JM, Bhalla N, Bourne PE, Chalfie M, Drubin DG, Fraser JS, Greider CW, Hendricks M, Jones C, Kiley R, King S, Kirschner MW, Krumholz HM, Lehmann R, Leptin M, Pulverer B, Rosenzweig B, Spiro JE, Stebbins M, Strasser C, Swaminathan S, Turner P, Vale RD, VijayRaghavan K, Wolberger C.

Science. 2016 May 20;352(6288):899-901. doi: 10.1126/science.aaf9133. No abstract available.

PMID:
27199406
13.

In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Helms HC, Abbott NJ, Burek M, Cecchelli R, Couraud PO, Deli MA, Förster C, Galla HJ, Romero IA, Shusta EV, Stebbins MJ, Vandenhaute E, Weksler B, Brodin B.

J Cereb Blood Flow Metab. 2016 May;36(5):862-90. doi: 10.1177/0271678X16630991. Epub 2016 Feb 11. Review.

14.

Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells.

Stebbins MJ, Wilson HK, Canfield SG, Qian T, Palecek SP, Shusta EV.

Methods. 2016 May 15;101:93-102. doi: 10.1016/j.ymeth.2015.10.016. Epub 2015 Oct 27.

15.

The design and validation of a magnetic resonance imaging-compatible device for obtaining mechanical properties of plantar soft tissue via gated acquisition.

Williams ED, Stebbins MJ, Cavanagh PR, Haynor DR, Chu B, Fassbind MJ, Isvilanonda V, Ledoux WR.

Proc Inst Mech Eng H. 2015 Oct;229(10):732-42. doi: 10.1177/0954411915606150.

PMID:
26405098
16.

Hispanic Subgroups, Acculturation, and Substance Abuse Treatment Outcomes.

Chartier KG, Carmody T, Akhtar M, Stebbins MB, Walters ST, Warden D.

J Subst Abuse Treat. 2015 Dec;59:74-82. doi: 10.1016/j.jsat.2015.07.008. Epub 2015 Jul 26.

17.

Explaining the frequency of alcohol consumption in a conflict zone: Jews and Palestinians in Israel.

Massey Z, Chartier KG, Stebbins MB, Canetti D, Hobfoll SE, Hall BJ, Shuval K.

Addict Behav. 2015 Jul;46:31-8. doi: 10.1016/j.addbeh.2015.02.003. Epub 2015 Feb 14.

18.

Pharmacy students teaching prescribers strategies to lower prescription drug costs for underserved patients.

Stebbins MR, Frear ME, Cutler TW, Lightwood JM, Fingado AR, Lai CJ, Lipton HL.

J Manag Care Pharm. 2013 Sep;19(7):534-41.

19.

The damaging effects of short chain fatty acids on Escherichia coli membranes.

Royce LA, Liu P, Stebbins MJ, Hanson BC, Jarboe LR.

Appl Microbiol Biotechnol. 2013 Sep;97(18):8317-27. doi: 10.1007/s00253-013-5113-5. Epub 2013 Aug 3.

20.

Promoting interprofessional collaboration: pharmacy students teaching current and future prescribers about Medicare Part D.

Lai CJ, Smith AR, Stebbins MR, Cutler TW, Lipton HL.

J Manag Care Pharm. 2011 Jul-Aug;17(6):439-48.

21.

Promoting access and reducing expected out-of-pocket prescription drug costs for vulnerable Medicare beneficiaries: a pharmacist-directed model.

Cutler TW, Stebbins MR, Smith AR, Patel RA, Lipton HL.

Med Care. 2011 Apr;49(4):343-7. doi: 10.1097/MLR.0b013e318202a9f2.

PMID:
21407030
22.

Neuroblastoma: management of a common childhood malignacy.

Stebbins M.

JAAPA. 2010 Nov;23(11):24-6, 51. No abstract available.

PMID:
21086886
23.

Peer-to-peer interprofessional health policy education for Medicare part D.

Lipton HL, Lai CJ, Cutler TW, Smith AR, Stebbins MR.

Am J Pharm Educ. 2010 Aug 10;74(6):102.

24.

A population study of the frequency of high-dose acetaminophen prescribing and dispensing.

Albertson TE, Walker VM Jr, Stebbins MR, Ashton EW, Owen KP, Sutter ME.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1191-5. doi: 10.1345/aph.1P012. Epub 2010 Jun 15.

PMID:
20551297
25.

Cost minimization of medicare part D prescription drug plan expenditures.

Patel RA, Lipton HL, Cutler TW, Smith AR, Tsunoda SM, Stebbins MR.

Am J Manag Care. 2009 Aug;15(8):545-53.

26.

Medicare part D community outreach train-the-trainer program for pharmacy faculty.

Stebbins MR, Cutler TW, Corelli RL, Smith AR, Lipton HL.

Am J Pharm Educ. 2009 May 27;73(3):53.

27.

Problem-based learning using the online Medicare Part D Plan Finder tool.

Cutler TW, Stebbins MR, Lai E, Smith AR, Lipton HL.

Am J Pharm Educ. 2008 Jun 15;72(3):47.

29.

Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphoma.

Rusk A, Cozzi E, Stebbins M, Vail D, Graham J, Valli V, Henkin J, Sharpee R, Khanna C.

Clin Cancer Res. 2006 Dec 15;12(24):7456-64.

30.

Public access failure at PubMed.

Stebbins M, Davis E, Royland L, White G.

Science. 2006 Jul 7;313(5783):43. No abstract available.

PMID:
16825550
31.

Managing the unmanageable: the nature and impact of drug risk in physician groups.

Lipton HL, Agnew JD, Stebbins MR, Kuo A, Dudley RA.

J Health Polit Policy Law. 2005 Aug;30(4):719-50. Erratum in: J Health Polit Policy Law. 2006 Jun;31(3):720.

PMID:
16318167
32.

Prescription drug dispensing limits and patterns.

Phillips KA, Liang SY, Haas JS, Stebbins M, Alldredge BK.

Manag Care Interface. 2005 Jul;18(7):41-6.

PMID:
16060485
33.

The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services.

Stebbins MR, Kaufman DJ, Lipton HL.

J Manag Care Pharm. 2005 May;11(4):333-41.

34.

The effects of patient positioning and slice selection on canine acetabular angle assessment with computed tomography.

Wang SI, Mathews KG, Robertson ID, Stebbins M, Trumpatori BJ.

Vet Radiol Ultrasound. 2005 Jan-Feb;46(1):39-43.

PMID:
15693557
35.

Outcome of cats with diarrhea and Tritrichomonas foetus infection.

Foster DM, Gookin JL, Poore MF, Stebbins ME, Levy MG.

J Am Vet Med Assoc. 2004 Sep 15;225(6):888-92.

PMID:
15485048
36.

Prevalence of and risk factors for feline Tritrichomonas foetus and giardia infection.

Gookin JL, Stebbins ME, Hunt E, Burlone K, Fulton M, Hochel R, Talaat M, Poore M, Levy MG.

J Clin Microbiol. 2004 Jun;42(6):2707-10.

37.
38.

Clinicopathological abnormalities and treatment response in 24 dogs seroreactive to Bartonella vinsonii (berkhoffii) antigens.

Breitschwerdt EB, Blann KR, Stebbins ME, Muñana KR, Davidson MG, Jackson HA, Willard MD.

J Am Anim Hosp Assoc. 2004 Mar-Apr;40(2):92-101.

PMID:
15007043
39.

Serosurvey of antiBabesia antibodies in stray dogs and American pit bull terriers and American staffordshire terriers from North Carolina.

Birkenheuer AJ, Levy MG, Stebbins M, Poore M, Breitschwerdt E.

J Am Anim Hosp Assoc. 2003 Nov-Dec;39(6):551-7.

PMID:
14736721
40.

Financial risk relationships and adoption of management strategies in physician groups for self-administered injectable drugs.

Agnew JD, Stebbins MR, Hickman DE, Lipton HL.

J Manag Care Pharm. 2003 Nov-Dec;9(6):523-33.

41.

Demographic, clinical, and radiographic features of bronchiectasis in dogs: 316 cases (1988-2000).

Hawkins EC, Basseches J, Berry CR, Stebbins ME, Ferris KK.

J Am Vet Med Assoc. 2003 Dec 1;223(11):1628-35.

PMID:
14664451
42.

Clinical evaluation of a right-sided prophylactic gastropexy via a grid approach.

Steelman-Szymeczek SM, Stebbins ME, Hardie EM.

J Am Anim Hosp Assoc. 2003 Jul-Aug;39(4):397-402.

PMID:
12873031
43.

Percutaneous ultrasound-guided cholecystocentesis in healthy cats.

Savary-Bataille KC, Bunch SE, Spaulding KA, Jackson MW, Law JM, Stebbins ME.

J Vet Intern Med. 2003 May-Jun;17(3):298-303.

44.

Use of a commercially available culture system for diagnosis of Tritrichomonas foetus infection in cats.

Gookin JL, Foster DM, Poore MF, Stebbins ME, Levy MG.

J Am Vet Med Assoc. 2003 May 15;222(10):1376-9.

PMID:
12762381
45.

Comparison of radiographic assessments of the tibial plateau slope in dogs.

Baroni E, Matthias RR, Marcellin-Little DJ, Vezzoni A, Stebbins ME.

Am J Vet Res. 2003 May;64(5):586-9.

PMID:
12755299
46.

Health survey of wild and captive bog turtles (Clemmys muhlenbergii) in North Carolina and Virginia.

Brenner D, Lewbart G, Stebbins M, Herman DW.

J Zoo Wildl Med. 2002 Dec;33(4):311-6.

PMID:
12564526
47.

Pharmacy-based intervention to reduce antibiotic use for acute bronchitis.

Hickman DE, Stebbins MR, Hanak JR, Guglielmo BJ.

Ann Pharmacother. 2003 Feb;37(2):187-91.

PMID:
12549944
48.

Ain't that a Sidekick in the head.

Stebbins M.

Nat Med. 2002 Oct;8(10):1085. No abstract available.

PMID:
12357243
49.

Antibody levels to hepatitis E virus in North Carolina swine workers, non-swine workers, swine, and murids.

Withers MR, Correa MT, Morrow M, Stebbins ME, Seriwatana J, Webster WD, Boak MB, Vaughn DW.

Am J Trop Med Hyg. 2002 Apr;66(4):384-8.

PMID:
12164292
50.

Supplemental Content

Loading ...
Support Center